ArticleOpen forum infectious diseases2025
Discontinuation of Long-acting Injectable Cabotegravir-Rilpivirine in a Large Clinic Cohort.
Katerina A Christopoulos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papertrialcites it